Browse by Speciality Area
Browse by Speciality Area
All Access Subscription
Get unlimited access to our full publication and article library.
Get Access NowInterested in Group Sales? Learn more
Among participants living with HIV who are at low-to-moderate risk for cardiovascular disease, those who received pitavastatin were 35% less likely to experience a major adverse cardiovascular event over a follow-up of approximately five years vs. those who received placebo.
Momelotinib can be prescribed to treat intermediate- or high-risk myelofibrosis.
How should one interpret the ECG in the figure? Is the rhythm most likely to be a re-entry supraventricular tachycardia with aberrant conduction?
CMS: COVID-19 Erased Quality Measure Improvements
Nearly 50% of quality measure results were worse than expected in 2021, including a surge in hospital-acquired infections.
As Predicted, Measles Returns in Unvaccinated
'Measles is a nasty virus.'
OTC Emergency Contraception Sharply Reduced Related ED Visits
Moving emergency contraception over the counter reduced ED visits by 96%. However, access barriers remain.
Stroke 2024: Advancing Therapy, Improving Outcomes provides evidence-based, cutting edge, clinical information on treating stroke and other neurological problems in a concise, accurate, and clinically relevant format. Written and edited by leading experts in the fields of neurology and emergency med...
Stroke 2023: Evolving Progress in Care provides evidence-based, cutting edge, clinical information on treating stroke and other neurological problems in a concise, accurate, and clinically relevant format. Written and edited by leading experts in the fields of neurology and emergency medicine, Strok...
STEMI Watch 2022: Strategic Advances in Care provides physicians and staff with a concise and practical update on ST-segment elevation myocardial infarction (STEMI).